NemaLife has developed a large-scale technology for whole-life studies in the worm C. elegans creating a new paradigm in high throughput screening. Our approach involves tracking the response of animals to thousands of interventions across life providing critical information on healthspan and overall survival. This discovery engine is expected to unleash new genetic targets and drugs for improving quality of life.

We offer custom high throughput screening services in humanized worm disease models. We employ microfluidic automation and distributed imaging to perform whole-life screening of thousands of compounds. We harness data-intelligence tools to provide phenotypic information related to changes in the neuromuscular system, behavior, reproductive system, healthspan and lifespan. Such comprehensive information will enable you to prioritize costly drug studies in mammalian models.